New Organ Chip Platform for Precision Oncology Predicts Chemotherapy Responses in Esophageal Adenocarcinoma Patients
Esophageal adenocarcinoma (EAC) represents one of the most formidable challenges in modern oncology, recognized as the sixth leading cause of ...
